December 25, 2013
Takeda Pharmaceutical said on December 20 that it has sealed an accord with US biotech Natrogen Therapeutics International Inc., which would grant the Japanese giant the exclusive development rights to Natura-alpha, an investigational drug for inflammatory bowel disease. Natura-alpha is...read more